Delivery Order SPE2DB20D2014-SPE2DB23FD19C
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,978,188 units of Vyvanse 40 mg capsules. The $1,567.08 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency, and has a completion date of June 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 40mg Vyvanse capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,150.57 and an ultimate completion date of May 24, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the prescription drug Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $2,422.08 and is a firm fixed-price delivery order, with a period of performance through July 8, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of 4,565,153,938 units of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on a firm fixed-price basis with a ceiling value of $6,580.88. The contract has a period of performance through July 16, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,930,073 units of the prescription medication Vyvanse 40 mg capsules. The contract has a ceiling value of $1,313.24 and a completion date of June 18, 2024. It was awarded by the Defense Logistics Agency (DLA) on June 17, 2024 as a firm fixed-price delivery order contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the delivery of 4,568,434,774 units of Vyvanse 40 mg capsules. The contract has a firm fixed price of $2,350.74 and a completion date of June 4, 2025. This is a non-set-aside delivery order contract, indicating open competition. Amerisourcebergen Drug Corp is a key supplier of pharmaceutical products and medical supplies to various...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 40 mg capsules. The contract has a total ceiling value of $1,010.82 and a period of performance through April 17, 2025. It is a delivery order contract with a firm-fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,761.14 firm fixed-price delivery order is for the supply of 100 units of Vyvanse 40 mg capsules. The contract has a completion date of September 6, 2024, with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,476.76 firm fixed-price delivery order is for the supply of 100 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of May 27, 2025 and was awarded on May 23, 2025. This award is not associated with a set-aside designation, indicating open competition....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $13,055.08, for the supply of Vyvanse 40 mg capsules. The contract has a ceiling value of $13,055.08 and an ultimate completion date of June 26, 2025. It is not designated as a set-aside contract, indicating open competition....
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB23FD19CDelivery Order
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of 4,562,001 units of the medication Vyvanse 40 mg capsules. The contract has a ceiling value of $10,009.14, with an ultimate completion date of August 28, 2023. The contract type is a Delivery Order, with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 8/25/23 |